Gliclazide
- Generic Name
- Gliclazide
- Brand Names
- Diamicron
- Drug Type
- Small Molecule
- Chemical Formula
- C15H21N3O3S
- CAS Number
- 21187-98-4
- Unique Ingredient Identifier
- G4PX8C4HKV
- Background
Gliclazide is an oral antihyperglycemic agent used for the treatment of non-insulin-dependent diabetes mellitus (NIDDM). It has been classified differently according to its drug properties in which based on its chemical structure, gliclazide is considered a first-generation sulfonylurea due to the structural presence of a sulfonamide group able to release a ...
- Indication
For the treatment of NIDDM in conjunction with diet and exercise.
- Associated Conditions
- Type 2 Diabetes Mellitus
- Associated Therapies
- -
Vildagliptin Compared to Gliclazide in Combination With Metformin in Patients With Type 2 Diabetes
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2005-01-31
- Last Posted Date
- 2020-12-17
- Lead Sponsor
- Novartis Pharmaceuticals
- Target Recruit Count
- 1007
- Registration Number
- NCT00102466
- Locations
- 🇩🇪
Investigative Centers, Nurnberg, Germany
🇨🇭Novartis Pharmaceuticals, Basel, Switzerland
Efficacy and Safety of Vildagliptin Compared to Gliclazide in Drug Naive Patients With Type 2 Diabetes
- First Posted Date
- 2005-01-31
- Last Posted Date
- 2016-11-18
- Lead Sponsor
- Novartis Pharmaceuticals
- Target Recruit Count
- 1092
- Registration Number
- NCT00102388
- Locations
- 🇩🇪
Novartis Investigative Site, Investigative Centers, Germany
🇨🇭Novartis Pharmaceuticals, Basel, Switzerland
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath